글로벌 로봇 심장 수술 시장 – 2031년까지의 산업 동향 및 예측

로봇 심장 수술 시장 분석 및 규모

로봇 심장 수술 시장은 기술과 방법의 발전으로 계속해서 급증하고 있습니다. 최신 로봇 시스템은 복잡한 심장 수술의 정밀도와 효율성을 향상시켜 시장 성장을 촉진합니다. 외과의는 이러한 혁신을 점점 더 활용하여 환자 결과를 개선하고 회복 시간을 단축하며 어려운 심혈관 질환을 더 정확하게 해결합니다. 이러한 추세는 심장학에서 로봇 지원 개입으로의 획기적인 전환을 강조합니다.                               

글로벌 로봇 심장 수술 시장 규모는 2023년에 5억 8,754만 달러로 평가되었으며, 2031년까지 1,5억 8,420만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 13.20%입니다. 이는 시장 가치를 나타냅니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

시장 정의

Robotic cardiology surgery refers to advanced procedures where robotic systems assist cardiologists in performing intricate cardiac surgeries with high precision. These systems use miniaturized instruments controlled by surgeons via computer console, enhancing accuracy and reducing recovery times compared to traditional methods. Robotic technology allows for minimally invasive procedures, reducing risks and improving outcomes for patients undergoing complex heart surgeries.            

Robotic Cardiology Surgery Market Dynamics

Drivers

• Increasing Telemedicine and Remote Surgery

Advances in robotic technology have revolutionized cardiology surgery by enabling telemedicine applications. Expert surgeons can now remotely perform complex procedures using robotic systems, expanding access to specialized care in remote or underserved areas. For instance, a surgeon in a major city can guide and operate a robotic system in a rural hospital, providing high-quality cardiac surgery without patients needing to travel long distances. This capability significantly drives market growth by enhancing accessibility and improving patient outcomes.

• Growing Minimally Invasive Surgery

Minimally invasive robotic surgery in cardiology allows surgeons to perform intricate procedures through small incisions, such as mitral valve repairs or coronary artery bypass grafting. This approach minimizes trauma to the patient's body, leading to faster recovery times and reduced risks of infection and bleeding compared to traditional open-heart surgery. As patients experience quicker healing and fewer complications, the demand for robotic cardiac surgery systems grows, driving market expansion globally.

Opportunities

• Growing Aging Population

As the global population ages, there is a rising need for cardiovascular treatments. Robotic surgery meets this demand by offering precise and effective procedures, appealing to both patients and healthcare providers. For instance, in developed countries such as the United States and Japan, where aging demographics are prominent, the adoption of robotic cardiology surgery has surged. This trend underscores the market's growth as it addresses the specific healthcare needs of an aging population effectively.

• Improved Patient Recovery

The adoption of minimally invasive robotic procedures in cardiology surgery is driving market growth by significantly improving patient recovery times. Compared to traditional open-heart surgeries, these advanced techniques often lead to shorter hospital stays and quicker rehabilitation periods. For instance, studies have shown that patients undergoing robotic-assisted heart surgery generally experience reduced pain and faster return to normal activities, which not only enhances patient outcomes but also increases demand for robotic systems in cardiac care.

Restraints/Challenges

• Risk of Technical Failures

The risk of technical failures in robotic systems during surgeries poses a significant barrier to market growth, as potential malfunctions may compromise patient safety and undermine confidence in the technology's reliability. This concern discourages widespread adoption among healthcare providers and patients. 

• High Cost of Robotic Systems

The high cost of robotic surgery systems limits their adoption in smaller healthcare facilities and developing regions, hindering market expansion. This financial barrier restricts access to advanced surgical technology, potentially disadvantaging patients who could benefit from robotic procedures. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In November 2022, MedTech start-up SS Innovations expanded its global presence by acquiring Avra Medical Robotics, a U.S. company specializing in surgical robot devices. This acquisition positions SS Innovations to enhance its capabilities and reach in the healthcare sector, aiming to innovate and improve surgical outcomes worldwide
• In November 2022, Accelus achieved U.S. FDA approval for its Remi Robotic Navigation System software update, enabling robotic-assisted pedicle screw placement in lumbar spine fixation surgeries. This milestone enhances Accelus's mission to advance minimally invasive surgery standards, offering surgeons precise tools for improved patient outcomes in spinal procedures
• In November 2022, Smith+Nephew introduced the JOURNEY II ROX Total Knee Solution, a reverse hybrid construct for total knee arthroplasty. Combining advanced bearing materials and anatomic design with cementless tibia fixation, this innovation aims to optimize surgical efficiency and potentially improve long-term outcomes for patients undergoing knee replacement
• In February 2022, Smith+Nephew launched its CORI Surgical System, a next-generation handheld robotics platform, in Japan. This advancement underscores Smith+Nephew's commitment to technological innovation in surgical robotics, empowering Japanese healthcare providers with advanced tools for precise and efficient orthopedic procedures

Robotic Cardiology Surgery Market Scope

The market is segmented on the basis of product and service, equipment type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

• Robotic Systems
• Instruments and Accessories
• Maintenance Services
• System Services

 Equipment Type

• Robot Machines
• Navigation Systems
• Planners and Simulators
• Others

End User

• Hospitals
• Research Centers

Robotic Cardiology Surgery Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product and service, equipment type, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the robotic cardiology surgery market in terms of both market share and revenue, bolstered by flexible regulatory frameworks and increasing adoption of innovative, technologically advanced products. This trend is anticipated to persist throughout the forecast period.

Europe is projected to exhibit the highest growth rate in the robotic cardiology surgery market, driven by expanding healthcare infrastructure and flexible compliance standards. These factors facilitate advancements in robotic surgery, enhancing precision and outcomes in cardiac procedures across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

이 시장은 또한 자본 장비에 대한 의료 지출의 모든 국가별 성장, 시장에 대한 다양한 종류의 제품의 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 시장에 미치는 영향에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 로봇 심장 수술 시장 점유율 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• Siemens Medical Solutions USA, Inc. (미국)
•  의료기기 비즈니스 서비스, Inc. (미국)
• Intuitive Surgical Operations, Inc. (미국)
• Accuray Incorporated. (미국)
•  존슨앤존슨 프라이빗 리미티드(미국)
• CAE Inc. (캐나다)
• 메드트로닉(아일랜드)
• 미래컴퍼니(주) (대한민국)
• Surgical Science Sweden AB(미국)
• Titan Medical Inc. (캐나다)
• Asensus Surgical US, Inc. (미국)
• 지멘스 헬스키니어스 AG(독일)

SKU-50558